Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor [Phase 4]
A Phase 4 clinical trial evaluating G-CSF alone or in combination with GM-CSF for prevention and treatment of infection in children with mal…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma [Phase 1, Phase 2]
Phase I/II trial evaluating Velcade (bortezomib) plus Zevalin in relapsed or refractory follicular lymphoma has terminated with results post…
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome [Phase 1]
Phase 1 trial investigating gemcitabine and pemetrexed disodium in advanced mycosis fungoides or Sézary syndrome (a form of cutaneous T-cell…
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia [Phase 2]
Phase 2 trial evaluating combination chemotherapy with rituximab for newly diagnosed Burkitt's lymphoma or leukemia has completed; results p…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer [Phase 2]
Phase 2 trial update on a combination chemotherapy, bone marrow transplant, and post-transplant cyclophosphamide regimen for hematologic can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Improving Communication in Older Cancer Patients and Their Caregivers [NA]
A completed clinical trial focused on improving communication in older cancer patients and their caregivers, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy [Phase 3]
A Phase 3 clinical trial comparing proton pump inhibitors versus histamine antagonists as an adjuvant to chemotherapy for lymphoma is curren…
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides [Phase 3]
A Phase 3 trial evaluating doxycycline for early-stage mycosis fungoides in lymphoma patients is underway, with efficacy results not yet spe…
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Lenalidomide and R-CHOP in B-cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial updating the combination of lenalidomide with R-CHOP in various B-cell lymphomas; study completed.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy [Phase 3]
Phase 3 trial ofInotuzumab Ozogamicin plus Rituximab for relapsed/refractory aggressive non-Hodgkin lymphoma in patients unsuitable for high…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant [Phase 2]
Phase 2 clinical trial update on CD34+ selection for partially matched family or matched unrelated adult donor transplants in leukemia and l…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow or stem cell transplantation in refractory Hodgkin's dise…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating busulfan plus clofarabine followed by allogeneic hematopoietic stem cell transplantation for leukemia and lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma [Phase 2]
Phase 2 clinical trial update on using chidamide maintenance after autologous stem cell transplantation in relapsed/refractory or high-risk …
-
FDA approval · 2018-07-27FDA Approved: LEUCOVORIN CALCIUM — Original Application (Fresenius Kabi USA, LLC)
FDA approved a generic Leucovorin Calcium under ANDA 207226 for Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS withdrawal · 2018-07-27Clinical Trial Update: Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies [Phase 1]
This Phase 1 trial of alisertib (MLN8237) in combination with brentuximab vedotin for relapsed/refractory CD30-positive lymphomas and CD30-p…
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma [NA]
A clinical trial update examining correlations between T-lymphocyte subsets and prognosis in autologous stem cell transplantation for lympho…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab [Phase 2]
Phase 2 trial update on optimized donor selection with nonmyeloablative bone marrow transplant using post-transplant cyclophosphamide and ri…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Evaluation of ClearLLab Leukemia and Lymphoma Panels
Completed clinical trial evaluating Beckman Coulter's ClearLLab leukemia and lymphoma panels for diagnostic use in leukemia and lymphoma con…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial investigating vorinostat and rituximab in indolent non-Hodgkin lymphoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
A completed clinical trial evaluating fluorodeoxyglucose-positron emission tomography (FDG-PET) for evaluating autoimmune lymphoproliferativ…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers [Phase 2]
Phase 2 trial evaluating reduced-intensity, related-donor bone marrow transplantation followed by high-dose cyclophosphamide for hematologic…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
The document reports the completion and update of a clinical trial evaluating loratadine for G-CSF–induced bone pain in patients with leukem…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain [Phase 2]
Phase 2 trial of pregabalin for G-CSF-induced bone pain in patients with breast cancer or lymphoma was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers [Phase 1, Phase 2]
Phase 1/2 open-label dose-escalation study of IONIS-STAT3Rx in patients with advanced cancers, including diffuse large B-cell lymphoma, has …